1. Tankhiwale, S. S., Jalgaonkar, S. V., Ahamad, S. & Hassani, U. Evaluation of extended spectrum beta lactamase in urinary isolates. Indian J. Med. Res. 120, 553–556 (2004).
2. Khurana, S., Taneja, N. & Sharma, M. Extended spectrum beta lactamases mediated resistance in urinary tract isolates of family Enterobacteriaceae. Indian J. Med. Res. 116, 145–149 (2002).
3. Younes, A., Hamouda, A., Dave, J. & Amyes, S. G. Prevalence of transferable blaCTX-M-15 from hospital- and community-acquired Klebsiella pneumoniae isolates in Scotland. J. Antimicrob. Chemother. 66, 313–318 (2011).
4. Baudry, P. J. et al. Mechanisms of resistance and mobility among multidrug-resistant CTX-M–producing Escherichia coli from Canadian intensive care units: the 1st report of QepA in North America. Diagn. Microbiol. Infect. Dis. 63, 319–326 (2009).
5. Yang, Y. S. et al. Community-onset bacteremic urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. J. Med. Sci. 29, 265–268 (2009).